Fosanis
AI-powered platform for cancer patients called Mika assists people affected by cancer over the course of their disease and therapy
Fosanis has raised €10M across 1 funding round from 4 investors, most recently a Series A round in May 2022. Based in Berlin, Germany; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€10M
€10,000,000
Funding rounds
1
Investors
4
distinct backers
Active since
2022-05
latest 2022-05
Funding by year
EUR raised per yearFosanis — funding by year — interactive chart.
Data table
| Fosanis — funding by year | |
|---|---|
| 2022 | €10M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-05-09 | Series A | €10M | Ananda Impact Ventures,Debiopharm Innovation Fund,EquityPitcher Ventures,Ship2B Ventures | View deal → |
Related news
Similar companies
same sector or country- Delivery Hero€7.1BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Helsing€2.9BGermany · AI
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
Global coverage: FundingData